相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Development of Mycobacterium avium Complex Lung Disease in Patients With Lung Cancer on Immune Checkpoint Inhibitors
Kohei Fujita et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Anti-PD-1 immunotherapy leads to tuberculosis reactivation via dysregulation of TNF-α
Liku B. Tezera et al.
ELIFE (2020)
Paradoxical response in a patient with non-small cell lung cancer who received nivolumab followed by anti-Mycobacterium tuberculosis agents
So Takata et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2019)
Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy
Irene Cortese et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Correlation between Disease Severity and the Intestinal Microbiome in Mycobacterium tuberculosis-Infected Rhesus Macaques
Sivaranjani Namasivayam et al.
MBIO (2019)
Tuberculosis following PD-1 blockade for cancer immunotherapy
Daniel L. Barber et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Defective positioning in granulomas but not lung-homing limits CD4 T-cell interactions with Mycobacterium tuberculosis-infected macrophages in rhesus macaques
K. D. Kauffman et al.
MUCOSAL IMMUNOLOGY (2018)
Host-directed therapies for bacterial and viral infections
Stefan H. E. Kaufmann et al.
NATURE REVIEWS DRUG DISCOVERY (2018)
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
V. Gopalakrishnan et al.
SCIENCE (2018)
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Bertrand Routy et al.
SCIENCE (2018)
Infectious complications associated with the use of immune checkpoint inhibitors in oncology: reactivation of tuberculosis after anti PD-1 treatment
H. Picchi et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies
Simon Tiberi et al.
LANCET INFECTIOUS DISEASES (2018)
The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients
Vyara Matson et al.
SCIENCE (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
PD-1 Expression on Mycobacterium tuberculosis-Specific CD4 T Cells Is Associated With Bacterial Load in Human Tuberculosis
Cheryl L. Day et al.
FRONTIERS IN IMMUNOLOGY (2018)
Combination anti-PD-1 and antiretroviral therapy provides therapeutic benefit against SIV
Geetha H. Mylvaganam et al.
JCI INSIGHT (2018)
The diverse functions of the PD1 inhibitory pathway
Arlene H. Sharpe et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Immune checkpoint blockade in infectious diseases
Michelle N. Wykes et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Anti-PD-1/PD-L1 therapy for infectious diseases: learning from the cancer paradigm
Martin Rao et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2017)
Anti-PD-1 Antibody Treatment Promotes Clearance of Persistent Cryptococcal Lung Infection in Mice
Jonathan A. Roussey et al.
JOURNAL OF IMMUNOLOGY (2017)
Pericardial Tamponade Caused by a Hypersensitivity Response to Tuberculosis Reactivation after Anti–PD-1 Treatment in a Patient with Advanced Pulmonary Adenocarcinoma
Yi-Chun Chu et al.
Journal of Thoracic Oncology (2017)
T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition
Enfu Hui et al.
SCIENCE (2017)
Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy
Sivaranjani Namasivayam et al.
MICROBIOME (2017)
Tuberculosis reactivation in a patient receiving anti-programmed death-1 (PD-1) inhibitor for relapsed Hodgkin's lymphoma
Joycelyn J. X. Lee et al.
ACTA ONCOLOGICA (2016)
Anti-PD1 Antibody Treatment and the Development of Acute Pulmonary Tuberculosis
Kohei Fujita et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Mice lacking Programmed cell death-1 show a role for CD8+ T cells in long-term immunity against blood-stage malaria
Joshua M. Horne-Debets et al.
SCIENTIFIC REPORTS (2016)
CD4 T Cell-Derived IFN-γ Plays a Minimal Role in Control of Pulmonary Mycobacterium tuberculosis Infection and Must Be Actively Repressed by PD-1 to Prevent Lethal Disease
Shunsuke Sakai et al.
PLOS PATHOGENS (2016)
A Quantitative Analysis of Complexity of Human Pathogen-Specific CD4 T Cell Responses in Healthy M. tuberculosis Infected South Africans
Cecilia S. Lindestam Arlehamn et al.
PLOS PATHOGENS (2016)
TIM3 Mediates T Cell Exhaustion during Mycobacterium tuberculosis Infection
Pushpa Jayaraman et al.
PLOS PATHOGENS (2016)
A Sterilizing Tuberculosis Treatment Regimen Is Associated with Faster Clearance of Bacteria in Cavitary Lesions in Marmosets
Laura E. Via et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Advancing host-directed therapy for tuberculosis
Robert S. Wallis et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
Katrin D. Mayer-Barber et al.
NATURE (2014)
Modeling Tuberculosis in Nonhuman Primates
Charles A. Scanga et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Mycobacterium tuberculosis Exploits Human Interferon γ to Stimulate Macrophage Extracellular Trap Formation and Necrosis
Ka-Wing Wong et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application
Taku Okazaki et al.
NATURE IMMUNOLOGY (2013)
The SILVA ribosomal RNA gene database project: improved data processing and web-based tools
Christian Quast et al.
NUCLEIC ACIDS RESEARCH (2013)
Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Noriho Iida et al.
SCIENCE (2013)
Biomarker Discovery by Sparse Canonical Correlation Analysis of Complex Clinical Phenotypes of Tuberculosis and Malaria
Juho Rousu et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
Viral acute lower respiratory infections impair CD8+ T cells through PD-1
John J. Erickson et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
PD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaques
Ravi Dyavar Shetty et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice
Helge Frebel et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
CD4 T Cells Promote Rather than Control Tuberculosis in the Absence of PD-1-Mediated Inhibition
Daniel L. Barber et al.
JOURNAL OF IMMUNOLOGY (2011)
Metagenomic biomarker discovery and explanation
Nicola Segata et al.
GENOME BIOLOGY (2011)
PD-1-PD-L1 pathway impairs Th1 immune response in the late stage of infection with Mycobacterium bovis bacillus Calmette-Guerin
Shunsuke Sakai et al.
INTERNATIONAL IMMUNOLOGY (2010)
QIIME allows analysis of high-throughput community sequencing data
J. Gregory Caporaso et al.
NATURE METHODS (2010)
Programmed death-1 (PD-1)-deficient mice are extraordinarily sensitive to tuberculosis
Eszter Lazar-Molnar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
PD-1 on dendritic cells impedes innate immunity against bacterial infection
Sheng Yao et al.
BLOOD (2009)
Target-Dependent B7-H1 Regulation Contributes to Clearance of Central Nervous Sysyem Infection and Dampens Morbidity
Timothy W. Phares et al.
JOURNAL OF IMMUNOLOGY (2009)
Enhancing SIV-specific immunity in vivo by PD-1 blockade
Vijayakumar Velu et al.
NATURE (2009)
Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal
Brian T. Fife et al.
NATURE IMMUNOLOGY (2009)
The PD-1/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungus Histoplasma capsulatum
Eszter Lazar-Molnar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma
DM Dorfman et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Restoring function in exhausted CD8 T cells during chronic viral infection
DL Barber et al.
NATURE (2006)
分享论文
